Suppr超能文献

基于大豆的产品的致敏性会因食品技术而改变。

The allergenicity of soybean-based products is modified by food technologies.

作者信息

Franck P, Moneret Vautrin D A, Dousset B, Kanny G, Nabet P, Guénard-Bilbaut L, Parisot L

机构信息

Laboratoire de Biochimie, Hôpital Central, Nancy, France.

出版信息

Int Arch Allergy Immunol. 2002 Jul;128(3):212-9. doi: 10.1159/000064254.

Abstract

BACKGROUND

Numerous products based on soybean are available and various food technologies are applied for their production. The allergenicity of natural soybean may be modified by these treatments.

OBJECTIVES

To compare the allergenicity of native soybean proteins with those of soy milk and texturized protein products. To show additional allergens.

METHODS

Three commercial products and two infant formulas were studied: Soybean flour, soy milk, texturized soy proteins, two infant formulas; the first containing total proteins and the second containing a soy protein hydrolysate. Sera from 9 patients allergic to soy protein were tested by immunoblotting (IB). IB inhibition was achieved by incubating sera with protein extract from soybean flour.

RESULTS

The SDS-PAGE profile of soybean flour protein and soy milk showed a difference in the proportions of the various protein fractions, with a higher concentration of 37-kD protein in flour and 33-kD protein in milk. Infant formula 1 contained proteins with a molecular weight below 28 kD. The texturized extract contained high proportions of 31- to 34- and 38-kD proteins. Immunoblotting revealed a lack of allergenicity in infant formula. Sera recognizing the 38- and 50-kD proteins in texturized soy protein also recognized the 37- and 49-kD proteins in soybean flour and in soy milk, suggesting a protein glycation by texturization processes. The 30- to 34-kD band in texturized proteins was devoid of any allergenicity. This study seems to indicate that the 30-kD allergen (Gly m Bd 30) disappears during the production of texturized soy protein.

CONCLUSION

All technologies applied to soybean-based products induce striking variation in the protein profile and allergenicity. Texturized protein could lack the major allergen Gly m Bd 30. Further studies or texturization might generate modified technologies in order to create hypoallergenic texturized proteins.

摘要

背景

有许多基于大豆的产品,并且各种食品技术被应用于它们的生产。这些处理可能会改变天然大豆的致敏性。

目的

比较天然大豆蛋白与豆浆和组织化蛋白产品的致敏性。展示额外的过敏原。

方法

研究了三种商业产品和两种婴儿配方奶粉:大豆粉、豆浆、组织化大豆蛋白、两种婴儿配方奶粉;第一种含有总蛋白,第二种含有大豆蛋白水解物。通过免疫印迹法(IB)检测9名对大豆蛋白过敏患者的血清。通过将血清与大豆粉蛋白提取物孵育实现IB抑制。

结果

大豆粉蛋白和豆浆的SDS-PAGE图谱显示各种蛋白质组分的比例存在差异,面粉中37-kD蛋白浓度较高,牛奶中33-kD蛋白浓度较高。婴儿配方奶粉1含有分子量低于28 kD的蛋白质。组织化提取物含有高比例的31至34 kD和38-kD蛋白质。免疫印迹显示婴儿配方奶粉无致敏性。识别组织化大豆蛋白中38-kD和50-kD蛋白的血清也识别大豆粉和豆浆中的37-kD和49-kD蛋白,表明组织化过程导致蛋白质糖基化。组织化蛋白质中30至34-kD条带无任何致敏性。这项研究似乎表明30-kD过敏原(Gly m Bd 30)在组织化大豆蛋白生产过程中消失。

结论

应用于大豆基产品的所有技术都会导致蛋白质谱和致敏性产生显著变化。组织化蛋白可能缺乏主要过敏原Gly m Bd 30。进一步的研究或组织化可能会产生改良技术,以创造低致敏性的组织化蛋白。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验